Norris Medicines Ltd
Norris Medicines Ltd (524414): company summary
Norris Medicines Ltd (524414) is a micro-cap Commercial Services company valued at ₹16 crore operating in Trading & Distributors on the NSE and BSE.
Norris Medicines Ltd (524414) is a micro-cap Commercial Services company valued at ₹16 crore operating in Trading & Distributors on the NSE and BSE.
- Financial performance
- Revenue has been shrinking at -0.9% a year over three years. Return on equity is 8.3%.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at -1.06 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Held back by growth (0.0). Scored on 3 of 5 measures.
DocStoX score
Low confidenceScored on 3 of 5 measures — the rest have no data for this company.
At a glance
Key highlights
- Low leverage — D/E 0.00
- Revenue shrinking 8% a year
- Loss-making in some of the last 5 years
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Commercial Services stocks · Trading & Distributors
Explore Norris Medicines Ltd’s valuation
Free deep-dive tools · no sign-up
Norris Medicines Ltd peers in Commercial Services
Other Commercial Services stocks on the NSE & BSE. See the full Commercial Services sector list.
Related tools & concepts
Value Norris Medicines Ltd with the ratios and calculators DocStoX uses in its analysis.

